Rinivent nasal spray

Rinivent is a well-known pharmaceutical product used for the symptomatic treatment of runny nose (rhinorrhea) associated with allergic or non-allergic rhinitis. The active ingredient, ipratropium bromide, was originally developed by the German pharmaceutical giant Boehringer Ingelheim. For markets such as Norway and Sweden, this specific brand is managed under the Boehringer Ingelheim portfolio.

Manufacturing for Rinivent typically occurs in specialized pharmaceutical facilities in Europe, specifically at Boehringer Ingelheim's manufacturing sites in Italy. The brand remains under the ownership of Boehringer Ingelheim, which is one of the world's largest private pharmaceutical companies, known for its focus on respiratory and cardiovascular health. The company is headquartered and remains controlled by the family in Ingelheim, Germany.